ATE236144T1 - Verfahren zur herstellung von (r)-3-hydroxy-4- butyrolacton, nützlich für die herstellung von (r)-carnitin - Google Patents

Verfahren zur herstellung von (r)-3-hydroxy-4- butyrolacton, nützlich für die herstellung von (r)-carnitin

Info

Publication number
ATE236144T1
ATE236144T1 AT98122322T AT98122322T ATE236144T1 AT E236144 T1 ATE236144 T1 AT E236144T1 AT 98122322 T AT98122322 T AT 98122322T AT 98122322 T AT98122322 T AT 98122322T AT E236144 T1 ATE236144 T1 AT E236144T1
Authority
AT
Austria
Prior art keywords
hydroxy
producing
carnitine
production
butyrolactone
Prior art date
Application number
AT98122322T
Other languages
English (en)
Inventor
Fabio Giannessi
Maria Ornella Tinti
Angelis Francesco De
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Application granted granted Critical
Publication of ATE236144T1 publication Critical patent/ATE236144T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/30—Preparation of optical isomers
    • C07C227/32—Preparation of optical isomers by stereospecific synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/02—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D305/10—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having one or more double bonds between ring members or between ring members and non-ring members
    • C07D305/12—Beta-lactones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT98122322T 1997-12-16 1998-11-24 Verfahren zur herstellung von (r)-3-hydroxy-4- butyrolacton, nützlich für die herstellung von (r)-carnitin ATE236144T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT97RM000780A IT1297120B1 (it) 1997-12-16 1997-12-16 Procedimento per la produzione di (r)-3-idrossi-4-butirrolattone utile nella preparazione della (r)-carnitina

Publications (1)

Publication Number Publication Date
ATE236144T1 true ATE236144T1 (de) 2003-04-15

Family

ID=11405401

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98122322T ATE236144T1 (de) 1997-12-16 1998-11-24 Verfahren zur herstellung von (r)-3-hydroxy-4- butyrolacton, nützlich für die herstellung von (r)-carnitin

Country Status (13)

Country Link
US (1) US6127552A (de)
EP (1) EP0924206B1 (de)
JP (1) JPH11236382A (de)
KR (1) KR100516475B1 (de)
AT (1) ATE236144T1 (de)
CA (1) CA2256033A1 (de)
DE (1) DE69812858T2 (de)
DK (1) DK0924206T3 (de)
ES (1) ES2195259T3 (de)
IT (1) IT1297120B1 (de)
PT (1) PT924206E (de)
TW (1) TW454003B (de)
ZA (1) ZA9811493B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1307303B1 (it) 1999-12-23 2001-10-30 Sigma Tau Ind Farmaceuti Idrolisi stereospecifica di esteri otticamente attivi.
MY139259A (en) * 1999-10-12 2009-09-30 Kvaerner Process Tech Ltd Process
CN104530060B (zh) * 2014-12-17 2016-08-24 新发药业有限公司 一种D-生物素关键中间体(3aS，6aR)-内酯的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06256334A (ja) * 1990-12-27 1994-09-13 Japan Tobacco Inc シスウイスキーラクトンの製造方法
CA2049536C (en) * 1991-05-13 1999-07-06 Rawle I. Hollingsworth Process for the preparation of 3,4-dihydroxybutanoic acid and salts thereof
IT1256705B (it) * 1992-12-21 1995-12-12 Sigma Tau Ind Farmaceuti Procedimento per la preparazione di l-(-)-carnitina a partire da un prodotto di scarto avente opposta configurazione.
IT1261230B (it) * 1993-04-08 1996-05-09 Sigma Tau Ind Farmaceuti Procedimento migliorato per la preparazione di l-(-)-carnitina a partire da suoi precursori aventi opposta configurazione.
IT1261231B (it) * 1993-04-08 1996-05-09 Sigma Tau Ind Farmaceuti Procedimento migliorato per la preparazione di l-(-)-carnitina a partire da un prodotto di scarto avente opposta configurazione.
IT1261489B (it) * 1993-07-29 1996-05-23 Sigma Tau Ind Farmaceuti Procedimento per la produzione di r amminocarnitina e s amminocarnitina.
JP3855033B2 (ja) * 1995-09-08 2006-12-06 高砂香料工業株式会社 光学活性３−ヒドロキシ−γ−ブチロラクトンの製造方法
IT1276207B1 (it) * 1995-09-29 1997-10-27 Sigma Tau Ind Farmaceuti Procedimento per la preparazione del (s)-b-idrossi-gamma- butirrolattone
US5808107A (en) * 1997-10-31 1998-09-15 Board Of Trustees Operating Michigan State University Process for the preparation of hydroxy substituted gamma butyrolactones

Also Published As

Publication number Publication date
EP0924206B1 (de) 2003-04-02
IT1297120B1 (it) 1999-08-03
PT924206E (pt) 2003-07-31
EP0924206A1 (de) 1999-06-23
DE69812858D1 (de) 2003-05-08
ES2195259T3 (es) 2003-12-01
CA2256033A1 (en) 1999-06-16
HK1021975A1 (en) 2000-07-21
DK0924206T3 (da) 2003-07-28
ZA9811493B (en) 1999-06-18
JPH11236382A (ja) 1999-08-31
KR100516475B1 (ko) 2005-11-25
US6127552A (en) 2000-10-03
TW454003B (en) 2001-09-11
KR19990063080A (ko) 1999-07-26
DE69812858T2 (de) 2004-01-29
ITRM970780A1 (it) 1999-06-16

Similar Documents

Publication Publication Date Title
DE69631305D1 (de) Verfahren zur Herstellung von Polymilchsäure
ATE121066T1 (de) Verfahren zur herstellung von 6,12-dihydro-6- hydroxy-cannabidiol und dessen anwendung zur herstellung von trans-delta-9- tetrahydrocannabinol.
DE69521175D1 (de) Verfahren zur Herstellung von Xanthangummi
DE69418581D1 (de) Verfahren zur herstellung dünner bleche, geeignet für die anfertigung von dosenteilen
ATE201025T1 (de) Verfahren zur herstellung von cephalosporinen und zwischenprodukte in diesem verfahren
DE59505084D1 (de) Kontinuierliches Verfahren zur Herstellung von organischen Isocyanaten
ATE210631T1 (de) Verfahren zur herstellung von iohexol
DE69812858D1 (de) Verfahren zur Herstellung von (R)-3-Hydroxy-4-Butyrolacton, nützlich für die Herstellung von (R)-Carnitin
DE60015563D1 (de) Verfahren zur herstellung von benzoperhydroisoindolen
ATE387425T1 (de) Verfahren zur herstellung von bicalutamid
DE4481274T1 (de) Umweltschützendes Verfahren zur Herstellung von Knöpfen für die Kleidung
ATE277919T1 (de) Verfahren zur herstellung von baccatin iii- derivativen
DE50105715D1 (de) Verfahren zur herstellung von dnda
ATE411978T1 (de) Verfahren zur herstellung von alpha-aminoketonen
ATE132535T1 (de) Verfahren zur diskontinuierlichen herstellung von l-carnitin auf mikrobiologischem weg
DE59807664D1 (de) Verfahren zur herstellung von 3-cyano-2,4-dihalogen-5-fluor-benzoesäuren
ATE272038T1 (de) Verfahren zur herstellung von 2-alkyl-3- chlorphenolen
ATE241630T1 (de) Verfahren zur herstellung von ucn-01
DE59408059D1 (de) Verfahren zur Herstellung von Dentalprothesen
ATE174333T1 (de) Verfahren zur herstellung von (s)-beta-hydroxy- gamma-butirolactone
WO2003106432A8 (de) Verfahren zur herstellung von 4,6-dichlor-5-fluorpyrimidin
ATE401299T1 (de) Verfahren für die herstellung von hydroxyethylaminen
ATE271053T1 (de) Verfahren zur herstellung von beta-hydroxyestern
DE69523824D1 (de) Stereoselektives Verfahren zur Herstellung von endo-Tropanamin und ähnlichen Verbindungen
DE59610411D1 (de) Verfahren zur Herstellung von gemusterten Textilien

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0924206

Country of ref document: EP

REN Ceased due to non-payment of the annual fee